AzTrials
AzTrials

Preterm InfantVANILLENCT03626974

The Calming Effect of Vanilla Odor on Preterm Infant Without Mother's Breast Milk Feeding

A study testing Venipuncture and Diffuser spreading odor in people with Preterm Infant, run by Assistance Publique Hopitaux De Marseille at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Pain is a frequent occurrence during the early life of premature newborns. Studies on the short term effects of pain, and potential for long-term ones, have shown that pain affects various physiological and behaviorial parameters. Read more about this study

Who is it for?
Ages Up to 10 days
Conditions the study is for
Preterm Infant
What is being tested?
Venipuncture and Diffuser spreading odor
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteFrance
Study dates
4 Mar 2019to 7 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 10 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Nourished with donated or artificial breast milk
  • Term of the certain child
  • Child whose post-natal age is less than or equal to 10 days at the time of inclusion
  • Eutrophic child
  • Child of a non-diabetic mother
  • Clinically stable child
Show all 10Show fewer
  • Stop Control Positive Airway Pressure (CPAP) nasal for 48 hours.
  • No analgesic or sedative drugs since birth
  • Child not presenting a gene syndrome, a progressive neurological disease, a malformative pathology, a cleft lip and palate
  • Child whose two parents or legal representatives have accepted their child's participation in this study, and have signed informed consent.

Who cannot join

  • Hypotrophic child greater than 5th percentile on the curves
  • Milk-fed child of a mother born to her own mother
  • Child over the age of 10 days
  • Child with grade 3-4 intraventricular hemorrhage, periventricular leukomalacia, or ulcerative necrotizing enterocolitis

Trial locations and contacts

1 site in 1 country.

France1 site
  • Assistance Publique Hôpitaux de Marseille

    Marseille, 13354

Other trials in France

About this study

Pain is a frequent occurrence during the early life of premature newborns. Studies on the short term effects of pain, and potential for long-term ones, have shown that pain affects various physiological and behaviorial parameters. Sucrose during a painful procedure reduce behaviorial and cardiac manifestations in preterm infant, but a recent study casts doubt on its efficacy. Analgesic treatments are available, but a large number of experimental studies in animals ended up with questioning the safety of their use in neonates, particularly in premature ones. Soothing and analgesic methods have been developed such nonnutritive suckling, sucrose, skin to skin contact, and breastfeeding. Therefore, it is important to explore other methods of analgesia. Recently, the role of olfaction as a soothing tool in full term newborns was examined in several studies. The olfactory system is more mature at birth than the others senses. The neonates reacted with significant facial and respiratory changes to low concentration of olfactory stimuli during the various behaviorial states. The analysis of olfacto-facial configurations revealed that behaviorial markers of disgust discriminated between some odors judged as pleasant and unpleasant by adults rather.

Objective The study was designed to assess the analgesic effect of vanilla odor on preterm neonates. The primary outcome was the Premature Infant Pain Profile (PIPP) score. The secondary outcomes were: the French scale Faceless Acute Neonatal pain Scale (FANS), salivary cortisol.

Read more

Study design This is a prospective, randomized, controlled, double-blind and monocentric trial. It is conducted in a level III maternity unit at the North Hospital in Marseille. The infant will feed without their own mother's breast milk, clinically stable, born between 30 and 36 weeks and 6 days gestational age, and of less than 10 days postnatal age. In both groups, the painful stimulus is a venipuncture for blood collection. In the experimental group, called "vanilla odor" group, the venipuncture will be performed on the neonate in the presence of a diffuser spreading the vanilla odor and ingestion of water. In the control group, the venipuncture will be performed with an odorless diffuser and ingestion of sucrose. Both group have non nutritive sucking. The diffuser will place under a Hood with an air-flow of 7 l/min. It will manually switch on 3 minutes before the venipuncture and switch off 3 minutes later. The type and quantity of vanillin to be used were determined during a pre-testing phase. Assessment Scale shows significant improvement in the neonates, with good interobserver agreement.

Attempt results A current randomized study compare effects of breast milk and vanilla odors, on premature neonate's pain during and after venipuncture. Our previous study has shown that maternal breast milk odor in preterm neonates reduces PIPP scores during a venipuncture and markedly reduces crying after this procedure. Therefore, from a clinical perspective, the odor of mother's own breast milk has an analgesic effect on the premature neonate. Olfactory stimulation using maternal breast milk odor could have other clinical implications in neonatal medicine in addition to pain prevention, as does olfactory stimulation with a pleasant vanilla-based odor. It could be integrated into developmental care of premature neonates.

Conditions
Preterm Infant
Being tested
Venipuncture, Diffuser spreading odor
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VenipunctureBiological

    Venipuncture for blood collection

  • Diffuser spreading odorDevice

    Diffuser will place under a Hood with an air-flow

Study groups in NCT03626974
Study groupRoleWhat they receive
Venipuncture with vanilla odorExperimentalthe venipuncture will be performed on the neonate in the presence of a diffuser spreading the vanilla odor and ingestion of water
Receives: Biological: Venipuncture; Device: Diffuser spreading odor
Venipuncture without odorPlacebo comparatorthe venipuncture will be performed with an odorless diffuser and ingestion of sucrose
Receives: Biological: Venipuncture; Device: Diffuser spreading odor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the Premature Infant Pain Profile (PIPP) score.

    Expression of behavioral signs after the venipuncture. 7 items including 3 behavioral, 2 physiological and 2 contextual, for a score from 0 to 21 depending on the term of the child. A score of at least 6 indicates a painful condition.

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2018
  2. Study start4 Mar 2019
  3. Primary completion19 Nov 2019
  4. Study completion7 May 2023

Why it stopped: investigator is gone

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03626974
Sponsor's protocol ID
2017-10
Other IDs
2017-A00496-47
Acronym
VANILLE
Status last verified
Jun 2023
First submitted
8 Aug 2018
Last updated
8 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Venipuncture and Diffuser spreading odor in people with Preterm Infant, run by Assistance Publique Hopitaux De Marseille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 8 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: investigator is gone). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the Premature Infant Pain Profile (PIPP) score. (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in